Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Nicole A. Doria‐Rose(National Institute of Allergy and Infectious Diseases), Mehul S. Suthar(Emory University), Mat Makowski(Emmes (United States)), Sarah O’Connell(ActionAid), Adrian B. McDermott(ActionAid), Britta Flach(ActionAid), Julie E. Ledgerwood(ActionAid), John R. Mascola(ActionAid), Barney S. Graham(ActionAid), Bob C. Lin(ActionAid), Sijy O’Dell(ActionAid), Stephen D. Schmidt(ActionAid), Alicia T. Widge(ActionAid), Venkata Viswanadh Edara(Emory University), Evan J. Anderson(Emory University), Lilin Lai(Emory University), Katharine Floyd(Emory University), Nadine Rouphael(Emory University), Veronika I. Zarnitsyna(Emory University), Paul C. Roberts(ActionAid), Mamodikoe Makhene(ActionAid), Wendy Buchanan(ActionAid), Catherine J. Luke(ActionAid), John H. Beigel(ActionAid), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Kathleen M. Neuzil(University of Maryland, Baltimore), Hamilton Bennett(Moderna Therapeutics (United States)), Brett Leav(Moderna Therapeutics (United States)), Jim Albert(Emmes (United States)), Pratap Kunwar(Emmes (United States))
Cited by 752Open Access
Abstract
Persistence of Antibody after mRNA-1273 Vaccination A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months ...
Related Papers
No related papers found
Powered by citation graph analysis